Glass Health vs MyoVista wavECG
Glass Health charges $0 to $200 per month. Lite has limited scribing and decision support, Lite and Starter carry ad sponsorships, Pro at $90 is ad-free, and only Max at $200 includes the Epic, athenahealth, eClinicalWorks and Elation workflows the vendor calls assisted. A small clinic on one of those EHRs that wants an ambient scribe and a cited differential in the exam room is the Glass Max buyer. Note drafting and ECG review are separate jobs in a clinic. HeartSciences has no public price, and its homepage links an Epic showroom listing. The company positions MyoVista Insights for a cardiology practice that wants longitudinal ECG comparison and an algorithm marketplace for third-party AI-ECG results, and its wavECG was cleared in October 2026 without an AI algorithm.
Decision support · Reviewed November 2, 2026
Glass Health
by Glass Health · founded 2021
DDx plus literature-grounded A&P plus ambient scribe in one workflow.
MyoVista wavECG
by HeartSciences
12-lead resting ECG device for cardiology clinics, FDA 510(k) cleared in October 2026 without its AI-ECG algorithm.
When to pick each one
Glass Health
- Max $200 per month adds EHR workflows
- Scribe plus cited differential in one product
- Free Lite tier for light scribing
MyoVista wavECG
- Epic showroom listing linked from vendor homepage
- Vendor describes ECG management across several devices
Score
Each row shows points earned of points available under the published rubric.
Glass Health
42of 100
MyoVista wavECG
31of 100
| Dimension | Glass Health | MyoVista wavECG | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 12 / 12 | -12 |
| HIPAA / SOC2 / BAA | 6 / 10 | 6 / 10 | 0 |
| EHR integrations (count) | 2.8 / 5.6 | 1.7 / 5.6 | +1.1 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 3.4 / 4.8 | 1.9 / 4.8 | +1.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 8.4 / 21 | 0 / 21 | +8.4 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 8.4 / 12 | 3 / 12 | +5.4 |
| Pricing transparency | 2.5 / 2.5 | 1.3 / 2.5 | +1.3 |
| Years in market | 4.2 / 6 | 0 / 6 | +4.2 |
Scroll horizontally to see every column.
Pricing
Glass Health
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Lite | n/a | n/a | Limited scribing and clinical decision support. Carries ad sponsorships. |
| Starter | $20 | n/a | Carries ad sponsorships. |
| Pro | $90 | n/a | Most popular tier, ad-free. |
| Max | $200 | n/a | For clinics. EHR integration (Athena, Epic, eCW, Elation) is available only on this tier. |
MyoVista wavECG
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Glass Health
FDA decisions
No FDA decision cited in our research as of October 26, 2026.
Peer-reviewed
1 PubMed record names Glass Health.
Community
1 post sourced: 0 positive, 1 neutral, 0 negative.
MyoVista wavECG
FDA decisions
K260005 (opens in new tab)510(k)2026-10-05
MyoVista wavECG (DG-200-B15-003)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Glass Health | MyoVista wavECG |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Epic, athenahealth, eClinicalWorks, Elation | Epic |
| Founded | 2021 | n/a |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.